
We are excited to offer the latest treatment for Dry eye syndrome, Ocular Rosacea, Ocular surface disease, Blepharitis, Demodex, Meibomian gland dysfunction, and Styes/Chalazion (internal or external hordeleums).

Optomap retinal imaging is a non-invasive technology used in optometry to capture a wide-field image of the retina. This imaging technique provides a detailed view of the back of the eye, including the retina, optic nerve, and blood vessels, without the need for dilation in many cases.

OCT‑A stands for Optical Coherence Tomography Angiography — an advanced, non‑invasive eye imaging technology that goes beyond standard OCT by allowing doctors to visualize blood vessels inside the retina and choroid with high resolution, in three dimensions.

At Cincinnati Vision Group, we’re committed to giving our patients the most thorough and comfortable care possible. That’s why we use RETeval®, a handheld, non-invasive device that measures how well your retina is functioning. This advanced test helps us detect eye conditions earlier and with greater accuracy — often before changes are visible on standard imaging.

At Cincinnati Vision Group, we use the latest technology to understand the root causes of dry eye—because effective treatment starts with an accurate diagnosis. One of the most important tools we use is MeiboVue®, a high-resolution meibography system designed to evaluate the health of your meibomian glands.